Filip Lardon

8.5k total citations · 1 hit paper
170 papers, 6.4k citations indexed

About

Filip Lardon is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Filip Lardon has authored 170 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Oncology, 82 papers in Molecular Biology and 35 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Filip Lardon's work include Lung Cancer Treatments and Mutations (24 papers), Cancer-related Molecular Pathways (19 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Filip Lardon is often cited by papers focused on Lung Cancer Treatments and Mutations (24 papers), Cancer-related Molecular Pathways (19 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Filip Lardon collaborates with scholars based in Belgium, Netherlands and United States. Filip Lardon's co-authors include Patrick Pauwels, Jan B. Vermorken, Marc Peeters, An Wouters, Vanessa Deschoolmeester, Marc Baay, Bea Pauwels, Evelien Smits, Marc Lenjou and Julie Jacobs and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Filip Lardon

168 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The potential and controversy of targeting STAT family members in cancer

2019 273 citations Yannick Verhoeven, Julie Jacobs et al. profile →

Peers

Filip Lardon

ONCOL

IMMUN

PRM

Stefano Indraccolo Italy

Emina H. Huang United States

Yohei Miyagi Japan

Catherine O′Brien Canada

Thomas Rutherford United States

Anne‐Marie Mes‐Masson Canada

Henrik J. Ditzel Denmark

Delong Liu United States

David Horst Germany

Jian Ma China

Stefano Indraccolo Italy

Filip Lardon

3.5k ×1.2

2.5k ×0.9

ONCOL

1.4k ×0.9

IMMUN

2.2k ×1.8

828 ×0.8

PRM

Citations per year, relative to Filip Lardon Filip Lardon (= 1×) peers Stefano Indraccolo

Countries citing papers authored by Filip Lardon

Since Specialization

Citations

This map shows the geographic impact of Filip Lardon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filip Lardon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filip Lardon more than expected).

Fields of papers citing papers by Filip Lardon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filip Lardon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filip Lardon. The network helps show where Filip Lardon may publish in the future.

Co-authorship network of co-authors of Filip Lardon

This figure shows the co-authorship network connecting the top 25 collaborators of Filip Lardon. A scholar is included among the top collaborators of Filip Lardon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filip Lardon. Filip Lardon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Audenaerde, Jonas R.M. Van, Jorrit De Waele, Christophe Hermans, et al.. (2025). Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma. OncoImmunology. 14(1). 2512104–2512104.

Deben, Christophe, Laurie Freire Boullosa, Edgar Cardenas De La Hoz, et al.. (2024). Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition. Journal of Experimental & Clinical Cancer Research. 43(1). 8 indexed citations

Deben, Christophe, Edgar Cardenas De La Hoz, Steve Vanlanduit, et al.. (2024). Development and validation of the Normalized Organoid Growth Rate (NOGR) metric in brightfield imaging-based assays. Communications Biology. 7(1). 1612–1612. 3 indexed citations

Schoeters, Greet, Filip Lardon, Annelies Janssens, et al.. (2023). Protecting public health and the environment: towards a general ban on cellulose acetate cigarette filters in the European Union. Frontiers in Public Health. 11. 1282655–1282655. 1 indexed citations

Sorber, Laure, Bieke Van Dorst, Karen Zwaenepoel, et al.. (2022). NTRK Gene Fusion Detection in a Pan-Cancer Setting Using the Idylla GeneFusion Assay. Journal of Molecular Diagnostics. 24(7). 750–759. 11 indexed citations

Hoz, Edgar Cardenas De La, Evelien Smits, Filip Lardon, et al.. (2022). Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis. Journal of Visualized Experiments. 10 indexed citations

Domen, Andreas, Delphine Quatannens, Sara Zanivan, et al.. (2021). Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer. Cancers. 13(5). 987–987. 42 indexed citations

Sorber, Laure, Bart Claes, Karen Zwaenepoel, et al.. (2021). Evaluation of Cytologic Sample Preparations for Compatibility With Nucleic Acid Analysis. American Journal of Clinical Pathology. 157(2). 293–304. 9 indexed citations

Pauw, Ines De, Filip Lardon, Jolien Van den Bossche, et al.. (2019). Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib. Cancers. 11(1). 98–98. 14 indexed citations

10.

Sorber, Laure, Karen Zwaenepoel, Julie Jacobs, et al.. (2019). Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol. Cancers. 11(4). 458–458. 74 indexed citations

11.

Bossche, Jolien Van den, Andreas Domen, Marc Peeters, et al.. (2019). Radiosensitization of Non-Small Cell Lung Cancer Cells by the Plk1 Inhibitor Volasertib Is Dependent on the p53 Status. Cancers. 11(12). 1893–1893. 9 indexed citations

12.

Sorber, Laure, Karen Zwaenepoel, Julie Jacobs, et al.. (2019). Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions. Molecular Diagnosis & Therapy. 24(1). 113–124. 35 indexed citations

13.

Krayem, Mohammad, Ahmad Najem, An Wouters, et al.. (2019). The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. Cancers. 11(8). 1093–1093. 20 indexed citations

14.

Jacobs, Julie, Vanessa Deschoolmeester, Karen Zwaenepoel, et al.. (2018). Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation. OncoImmunology. 7(7). e1440167–e1440167. 45 indexed citations

15.

Deben, Christophe, Vanessa Deschoolmeester, Jorrit De Waele, et al.. (2018). Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress. Cancers. 10(4). 126–126. 46 indexed citations

16.

Vangestel, Christel, An Wouters, Patrick Pauwels, et al.. (2016). Efficacy Screening of Gloriosa Superba Extracts in a Murine Pancreatic Cancer Model Using ¹⁸ F-FDG PET/CT for Monitoring Treatment Response. Cancer Biotherapy and Radiopharmaceuticals. 31(3). 99–109. 13 indexed citations

17.

Steen, Nele Van Der, Christophe Deben, Vanessa Deschoolmeester, et al.. (2016). Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer. World Journal of Clinical Oncology. 7(6). 425–425. 9 indexed citations

18.

Boeckx, Carolien, Ken Op de Beeck, Ridha Limame, et al.. (2015). Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor.. PubMed Central. 5(6). 1921–38. 24 indexed citations

19.

Hengst, W., Jeroen Hendriks, Bram Balduyck, et al.. (2014). Phase II Multicenter Clinical Trial of Pulmonary Metastasectomy and Isolated Lung Perfusion with Melphalan in Patients with Resectable Lung Metastases. Journal of Thoracic Oncology. 9(10). 1547–1553. 23 indexed citations

20.

Wouters, An, Bea Pauwels, Natalie Burrows, et al.. (2014). The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein. BMC Cancer. 14(1). 594–594. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact